Pat Hagan
This person does not yet have a bio.
February 2026
A Stubborn Gene, a Failed Experiment, and a New Path
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this IssueResearch Resources
Advancing Drug Discovery with Complex Human In Vitro Models
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
Redefining Immunology Through Advanced Technologies
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Maximizing Cancer Research Model Systems
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Products
Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.